BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 16481377)

  • 1. Frequent immune response to a melanocyte specific protein KU-MEL-1 in patients with Vogt-Koyanagi-Harada disease.
    Otani S; Sakurai T; Yamamoto K; Fujita T; Matsuzaki Y; Goto Y; Ando Y; Suzuki S; Usui M; Takeuchi M; Kawakami Y
    Br J Ophthalmol; 2006 Jun; 90(6):773-7. PubMed ID: 16481377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor antigens isolated from a patient with vitiligo and T-cell-infiltrated melanoma.
    Kiniwa Y; Fujita T; Akada M; Ito K; Shofuda T; Suzuki Y; Yamamoto A; Saida T; Kawakami Y
    Cancer Res; 2001 Nov; 61(21):7900-7. PubMed ID: 11691810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell recognition and cytokine profile induced by melanocyte epitopes in patients with HLA-DRB1*0405-positive and -negative Vogt-Koyanagi-Harada uveitis.
    Damico FM; Cunha-Neto E; Goldberg AC; Iwai LK; Marin ML; Hammer J; Kalil J; Yamamoto JH
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2465-71. PubMed ID: 15980237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular infiltrating CD4+ T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens.
    Sugita S; Takase H; Taguchi C; Imai Y; Kamoi K; Kawaguchi T; Sugamoto Y; Futagami Y; Itoh K; Mochizuki M
    Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2547-54. PubMed ID: 16723469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The association of HLA-DR4 gene subtypes with Vogt-Koyanagi-Harada syndrome].
    Xiao T; Jiang Y; You X
    Zhonghua Yan Ke Za Zhi; 1997 Jul; 33(4):268-71. PubMed ID: 10451958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Association of HLA-DRB genes with Vogt-Koyanagi-Harada syndrome in a Chinese Han population].
    Zhang M; Qiu C; Hu T
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Feb; 22(1):36-40. PubMed ID: 12903490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral immune response directed against LEDGF in patients with VKH.
    Yamada K; Senju S; Shinohara T; Nakatsura T; Murata Y; Ishihara M; Nakamura S; Ohno S; Negi A; Nishimura Y
    Immunol Lett; 2001 Oct; 78(3):161-8. PubMed ID: 11578690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of recognition of common melanocytic antigens by T cells isolated from the cerebrospinal fluid of a Vogt-Koyanagi-Harada patient.
    Abad S; Wieërs G; Colau D; Wildmann C; Delair E; Dhote R; Brézin AP; Kawakami Y; Coulie PG; van der Bruggen P
    Mol Vis; 2014; 20():956-69. PubMed ID: 24991188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of autoreactive T cells in Vogt-Koyanagi-Harada disease.
    Gocho K; Kondo I; Yamaki K
    Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2004-9. PubMed ID: 11481264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diminished frequency and function of CD4+CD25high regulatory T cells associated with active uveitis in Vogt-Koyanagi-Harada syndrome.
    Chen L; Yang P; Zhou H; He H; Ren X; Chi W; Wang L; Kijlstra A
    Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3475-82. PubMed ID: 18421089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological aspects of Behçet's and Vogt-Koyanagi-Harada's diseases.
    Ohno S
    Trans Ophthalmol Soc U K (1962); 1981 Sep; 101 (Pt 3)(3):335-41. PubMed ID: 6820735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ocular infiltrating CD 4+ T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens].
    Sugita S
    Nippon Ganka Gakkai Zasshi; 2008 Nov; 112(11):953-64. PubMed ID: 19069378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leptin increases in Vogt-Koyanagi-Harada (VKH) disease and promotes cell proliferation and inflammatory cytokine secretion.
    Liu L; Yang P; He H; Lin X; Jiang L; Chi W; Zhao C; Zhou H
    Br J Ophthalmol; 2008 Apr; 92(4):557-61. PubMed ID: 18245271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirement of Ia-positive nylon wool adherent cells for activation of cytotoxic T-lymphocytes specific to melanocyte-associated antigens in patients with Vogt-Koyanage-Harada's disease.
    Maezawa N; Yano A
    Jpn J Ophthalmol; 1988; 32(3):348-57. PubMed ID: 3265967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-23 promotes CD4+ T cells to produce IL-17 in Vogt-Koyanagi-Harada disease.
    Chi W; Yang P; Li B; Wu C; Jin H; Zhu X; Chen L; Zhou H; Huang X; Kijlstra A
    J Allergy Clin Immunol; 2007 May; 119(5):1218-24. PubMed ID: 17335887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dominance of activated T cells and interleukin-6 in aqueous humor in Vogt-Koyanagi-Harada disease.
    Norose K; Yano A; Wang XC; Tokushima T; Umihira J; Seki A; Nohara M; Segawa K
    Invest Ophthalmol Vis Sci; 1994 Jan; 35(1):33-9. PubMed ID: 8300361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel autoantigen UACA in patients with panuveitis.
    Yamada K; Senju S; Nakatsura T; Murata Y; Ishihara M; Nakamura S; Ohno S; Negi A; Nishimura Y
    Biochem Biophys Res Commun; 2001 Feb; 280(4):1169-76. PubMed ID: 11162650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A shared HLA-DRB1 epitope in the DR beta first domain is associated with Vogt-Koyanagi-Harada syndrome in Indian patients.
    Tiercy JM; Rathinam SR; Gex-Fabry M; Baglivo E
    Mol Vis; 2010 Mar; 16():353-8. PubMed ID: 20216938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanocyte lysis by cytotoxic T lymphocytes recognizing the MART-1 melanoma antigen in HLA-A2 patients with Vogt-Koyanagi-Harada disease.
    Sugita S; Sagawa K; Mochizuki M; Shichijo S; Itoh K
    Int Immunol; 1996 May; 8(5):799-803. PubMed ID: 8671669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of human leukocyte antigen HLA-DR beta amino acid sequence in Vogt-Koyanagi-Harada syndrome.
    Numaga J; Matsuki K; Tokunaga K; Juji T; Mochizuki M
    Invest Ophthalmol Vis Sci; 1991 Jun; 32(7):1958-61. PubMed ID: 2055689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.